1y57: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
[[Image:1y57.gif|left|200px]]
{{Seed}}
[[Image:1y57.png|left|200px]]


<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1y57|  PDB=1y57  |  SCENE=  }}  
{{STRUCTURE_1y57|  PDB=1y57  |  SCENE=  }}  


'''Structure of unphosphorylated c-Src in complex with an inhibitor'''
===Structure of unphosphorylated c-Src in complex with an inhibitor===




==Overview==
<!--
The regulation of the activity of Abl and Src family tyrosine kinases is mediated by intramolecular interactions between the SH3, SH2, and kinase (SH1) domains. We have determined the crystal structure of an unphosphorylated form of c-Src in which the SH2 domain is not bound to the C-terminal tail. This results in an open structure where the kinase domain adopts an active conformation and the C terminus binds within a hydrophobic pocket in the C-terminal lobe. NMR binding studies support the hypothesis that an N-terminal myristate could bind in this pocket, as observed for Abl, suggesting that c-Src may also be regulated by myristate binding. In addition, the structure contains a des-methyl analog of the antileukemia drug imatinib (STI571; Gleevec). This structure reveals why the drug shows a low affinity for active kinase conformations, contributing to its excellent kinase selectivity profile.
The line below this paragraph, {{ABSTRACT_PUBMED_15939018}}, adds the Publication Abstract to the page
(as it appears on PubMed at http://www.pubmed.gov), where 15939018 is the PubMed ID number.
-->
{{ABSTRACT_PUBMED_15939018}}


==Disease==
==Disease==
Line 36: Line 40:
[[Category: Sh2]]
[[Category: Sh2]]
[[Category: Sh3]]
[[Category: Sh3]]
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May  3 15:53:28 2008''
 
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 04:16:54 2008''